Yisha Liang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yisha Liang has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Aaron G. Schmidt
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA
1 shared publication - Benjamin L. Allsup
Department of Biological Engineering, MIT, Cambridge, MA, USA
1 shared publication - Bryan D. Bryson
Department of Biological Engineering, Massachusetts Institute of Technology
1 shared publication - Charles L. Evavold
Ragon Institute of MGH, MIT and Harvard
1 shared publication - Christopher S. Garris
Center for Systems Biology, Massachusetts General Hospital, Boston, USA
1 shared publication Emerson Glassey
Ragon Institute of Mass General, MIT, and Harvard, 600 Main Street, Cambridge, MA 02139, USA
1 shared publication
Latest Publications
- Open Access
Cholesterol constrains pore formation by mammalian gasdermins
Pyroptosis is a lytic form of cell death executed by gasdermin pores. Through a CRISPR screen to uncover macrophage genes required for gasdermin D (GSDMD) pore activity, we identify the endosome adaptor Rabgef1 as a positive regulator of pore formation. Rabgef1 deficiency preserves NT-GSDMD membrane binding but prevents NT-GSDMD oligomerization and lytic death. Mechanistic analyses revealed that Rabgef1 deficiency is associated with an overabundance of cholesterol in the plasma membrane. Cholesterol depletion or redistribution through multiple approaches restores GSDMD oligomerization and pyroptosis. The Rabgef1-mediated control of membrane cholesterol and pore formation was found to be a general regulator of the gasdermin family. In cancer cells, organoids, and tumors, cholesterol reduction sensitizes resistant cells to GSDME pyroptosis driven by synthetic mRNAs, chemogenetic induction, and chemotherapy treatment. These results establish membrane cholesterol content as an endogenous checkpoint for gasdermin-mediated pyroptotic cell death during the execution phase, with implications for metabolic disease and cancer immunotherapy.
Open AccessCholesterol constrains pore formation by mammalian gasdermins
Pyroptosis is a lytic form of cell death executed by gasdermin pores. Through a CRISPR screen to uncover macrophage genes required for gasdermin D (GSDMD) pore activity, we identify the endosome adaptor Rabgef1 as a positive regulator of pore formation. Rabgef1 deficiency preserves NT-GSDMD membrane binding but prevents NT-GSDMD oligomerization and lytic death. Mechanistic analyses revealed that Rabgef1 deficiency is associated with an overabundance of cholesterol in the plasma membrane. Cholesterol depletion or redistribution through multiple approaches restores GSDMD oligomerization and pyroptosis. The Rabgef1-mediated control of membrane cholesterol and pore formation was found to be a general regulator of the gasdermin family. In cancer cells, organoids, and tumors, cholesterol reduction sensitizes resistant cells to GSDME pyroptosis driven by synthetic mRNAs, chemogenetic induction, and chemotherapy treatment. These results establish membrane cholesterol content as an endogenous checkpoint for gasdermin-mediated pyroptotic cell death during the execution phase, with implications for metabolic disease and cancer immunotherapy.
- Open Access
- 8 January 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (2) , eabd9732
TRIM26 is a critical host factor for HCV replication and contributes to host tropism
A genome-wide screening revealed that TRIM26 is a host factor for HCV replication and a new determinant for host tropism.
- 8 January 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (2) , eabd9732
Open AccessTRIM26 is a critical host factor for HCV replication and contributes to host tropism
A genome-wide screening revealed that TRIM26 is a host factor for HCV replication and a new determinant for host tropism.